Position in NVCT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,234,980
+$1,036,614 QoQ
Shares Held
67,155
+161.7% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 82 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC Bancorp USA Inc. holds $206,102,437 across 82 Biotechnology names. NVCT ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,673 | $82,791,478 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
163,733 | $49,288,543 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,340 | $13,306,342 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
67,251 | $12,594,766 | |
| 5 | MRNA |
Moderna, Inc.
|
91,461 | $6,405,013 | |
| 6 | INCY |
Incyte Corp
|
46,088 | $5,224,534 | |
| 7 | TECH |
BIO-TECHNE Corp
|
64,401 | $4,549,929 | |
| 8 | PGEN |
Precigen, Inc.
|
499,912 | $2,849,498 |
All Filings in NVCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,360 | 944 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $1,217,620 | 66,211 | Principal | Defined | 2026-08-13 | |
| 2026-03-31 | $6,021 | 779 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $192,345 | 24,883 | Principal | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||